Annual Report 2019

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY For the year ended 31 December 2019 44 The United Laboratories International Holdings Limited Annual Report 2019 Attributable to owners of the Company Foreign Share Share Special Capital Revaluation exchange Retained capital premium reserve reserve reserve reserve profits Total RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 At 1 January 2018 15,237 2,356,763 277,100 763,404 95,616 2,659 1,930,986 5,441,765 Changes in equity during the year: Exchange differences arising on translation of a foreign operation – – – – – 615 – 615 Profit for the year – – – – – – 682,928 682,928 Total comprehensive income for the year – – – – – 615 682,928 683,543 Dividends recognised as distribution ( Note 15) – – – – – – (84,443) (84,443) Issue of shares upon conversion of convertible bonds (Note 32) 109 81,068 – – – – – 81,177 Appropriations – – – 82,813 – – (82,813) – At 31 December 2018 15,346 2,437,831 277,100 846,217 95,616 3,274 2,446,658 6,122,042 Changes in equity during the year: Exchange differences arising on translation of a foreign operation – – – – – (1,971) – (1,971) Profit for the year – – – – – – 641,764 641,764 Total comprehensive (expense) income for the year – – – – – (1,971) 641,764 639,793 Dividends recognised as distribution (Note 15) – – – – – – (98,383) (98,383) Issue of shares upon conversion of convertible bonds (Note 32) 14 8,323 – – – – – 8,337 Transfer of revaluation reverse upon disposal of a subsidiary – – – – (95,616) – 95,616 – Appropriations – – – 88,575 – – (88,575) – At 31 December 2019 15,360 2,446,154 277,100 934,792 – 1,303 2,997,080 6,671,789